dsm-firmenich files sclareol patent suit against Chinese producers and institute

dsm-firmenich has filed patent infringement litigation before the Xiong'An New District Court in Hebei Province, China, against several Chinese entities, including a sclareol producer and a research institute. The company alleges unauthorized use of its patent for producing sclareol, an intermediate used to make amber ingredients such as Ambrox Super. It is asking the court to order the defendants to stop the alleged use and pay compensation.

Key facts

Market context

Sclareol is a natural diterpene alcohol that serves as a key starting material for making ambergris-type odorants, most notably Ambrox and related molecules used to give warm, woody, amber character to perfumes and scented consumer products. Demand therefore runs mainly through fine fragrance, personal care, and household product makers, which value stable supply and consistent odor quality. Sclareol has traditionally been obtained from clary sage extraction, while modern routes increasingly rely on fermentation or biotechnological processes, so patent protection over those production methods can shape which producers are able to scale output. When patent disputes reach the production step, buyers may face shifts in the number of qualified suppliers, possible changes in intermediate availability, and pressure on contract pricing. Such cases are typically watched closely by fragrance houses and ingredient distributors assessing sourcing risk.

Source: official release on our-company.dsm-firmenich.com. Summary and context written by Market Krystal.